The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Treatment Market Research Report 2025
Synopsis
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
The global mRNA Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for mRNA Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Treatment.
Report Scope
The mRNA Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CureVac
Moderna
BioNTech (Pfizer)
Sanofi (Translate Bio)
Ethris (AstraZeneca)
Kernal Biologics
RaNA Therapeutics
Silence Therapeutics
Segment by Type
Vaccine
Drugs
Segment by Application
Protein Diseases
Gene Dysfunction Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
The global mRNA Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for mRNA Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Treatment.
Report Scope
The mRNA Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CureVac
Moderna
BioNTech (Pfizer)
Sanofi (Translate Bio)
Ethris (AstraZeneca)
Kernal Biologics
RaNA Therapeutics
Silence Therapeutics
Segment by Type
Vaccine
Drugs
Segment by Application
Protein Diseases
Gene Dysfunction Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global mRNA Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Protein Diseases
1.3.3 Gene Dysfunction Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Treatment Market Perspective (2019-2030)
2.2 mRNA Treatment Growth Trends by Region
2.2.1 Global mRNA Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Treatment Historic Market Size by Region (2019-2024)
2.2.3 mRNA Treatment Forecasted Market Size by Region (2025-2030)
2.3 mRNA Treatment Market Dynamics
2.3.1 mRNA Treatment Industry Trends
2.3.2 mRNA Treatment Market Drivers
2.3.3 mRNA Treatment Market Challenges
2.3.4 mRNA Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Treatment Players by Revenue
3.1.1 Global Top mRNA Treatment Players by Revenue (2019-2024)
3.1.2 Global mRNA Treatment Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Treatment Revenue
3.4 Global mRNA Treatment Market Concentration Ratio
3.4.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2023
3.5 mRNA Treatment Key Players Head office and Area Served
3.6 Key Players mRNA Treatment Product Solution and Service
3.7 Date of Enter into mRNA Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Treatment Breakdown Data by Type
4.1 Global mRNA Treatment Historic Market Size by Type (2019-2024)
4.2 Global mRNA Treatment Forecasted Market Size by Type (2025-2030)
5 mRNA Treatment Breakdown Data by Application
5.1 Global mRNA Treatment Historic Market Size by Application (2019-2024)
5.2 Global mRNA Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Treatment Market Size (2019-2030)
6.2 North America mRNA Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Treatment Market Size by Country (2019-2024)
6.4 North America mRNA Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Treatment Market Size (2019-2030)
7.2 Europe mRNA Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Treatment Market Size by Country (2019-2024)
7.4 Europe mRNA Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Treatment Market Size (2019-2030)
8.2 Asia-Pacific mRNA Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Treatment Market Size (2019-2030)
9.2 Latin America mRNA Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Treatment Market Size by Country (2019-2024)
9.4 Latin America mRNA Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Treatment Market Size (2019-2030)
10.2 Middle East & Africa mRNA Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CureVac
11.1.1 CureVac Company Detail
11.1.2 CureVac Business Overview
11.1.3 CureVac mRNA Treatment Introduction
11.1.4 CureVac Revenue in mRNA Treatment Business (2019-2024)
11.1.5 CureVac Recent Development
11.2 Moderna
11.2.1 Moderna Company Detail
11.2.2 Moderna Business Overview
11.2.3 Moderna mRNA Treatment Introduction
11.2.4 Moderna Revenue in mRNA Treatment Business (2019-2024)
11.2.5 Moderna Recent Development
11.3 BioNTech (Pfizer)
11.3.1 BioNTech (Pfizer) Company Detail
11.3.2 BioNTech (Pfizer) Business Overview
11.3.3 BioNTech (Pfizer) mRNA Treatment Introduction
11.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2019-2024)
11.3.5 BioNTech (Pfizer) Recent Development
11.4 Sanofi (Translate Bio)
11.4.1 Sanofi (Translate Bio) Company Detail
11.4.2 Sanofi (Translate Bio) Business Overview
11.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction
11.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2019-2024)
11.4.5 Sanofi (Translate Bio) Recent Development
11.5 Ethris (AstraZeneca)
11.5.1 Ethris (AstraZeneca) Company Detail
11.5.2 Ethris (AstraZeneca) Business Overview
11.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction
11.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2019-2024)
11.5.5 Ethris (AstraZeneca) Recent Development
11.6 Kernal Biologics
11.6.1 Kernal Biologics Company Detail
11.6.2 Kernal Biologics Business Overview
11.6.3 Kernal Biologics mRNA Treatment Introduction
11.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2019-2024)
11.6.5 Kernal Biologics Recent Development
11.7 RaNA Therapeutics
11.7.1 RaNA Therapeutics Company Detail
11.7.2 RaNA Therapeutics Business Overview
11.7.3 RaNA Therapeutics mRNA Treatment Introduction
11.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2019-2024)
11.7.5 RaNA Therapeutics Recent Development
11.8 Silence Therapeutics
11.8.1 Silence Therapeutics Company Detail
11.8.2 Silence Therapeutics Business Overview
11.8.3 Silence Therapeutics mRNA Treatment Introduction
11.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2019-2024)
11.8.5 Silence Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
